Systematic review: peginterferon vs. standard interferon in the treatment of chronic hepatitis C. - Wikidata - awgldk - TriplyDB

Systematic review: peginterferon vs. standard interferon in the treatment of chronic hepatitis C.

Systematic review: peginterferon vs. standard interferon in the treatment of chronic hepatitis C.

http://www.wikidata.org/entity/Q35544070

about

Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C Pegylated interferon alpha 2a versus pegylated interferon alpha 2b for chronic hepatitis C Pegylated interferon plus ribavirin versus non-pegylated interferon plus ribavirin for chronic hepatitis C Polo-like kinase 1 is involved in hepatitis C virus replication by hyperphosphorylating NS5A HCV drug discovery aimed at viral eradication.Effectiveness of alpha interferon (+ ribavirin) in the treatment of chronic viral hepatitis C genotypes 2 and 3 in a Brazilian sample.Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services.

P2860

Q24200189-12EDCE57-5A66-42EA-99A2-5AE429805313 Q24240315-3FCF3482-5A4A-45C5-992B-272BAABA66C1 Q24241360-9C861A70-29C1-45A2-8587-9FC0AA8D9CFE Q24318654-05239701-B4EE-4A2C-9B6B-B62000112635 Q37664059-A5E6B2B1-0722-4CCA-99C4-3D282F339991 Q42982020-BDB92751-F5A9-4DCD-9A48-48831D483A7C Q45205749-0444DC88-8D8C-411E-A6BC-BF8B50B220AE

P2860

Systematic review: peginterferon vs. standard interferon in the treatment of chronic hepatitis C.

http://www.wikidata.org/entity/Q35544070

description

2003 nî lūn-bûn

@nan

2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Systematic review: peginterfer ...... atment of chronic hepatitis C.

@ast

Systematic review: peginterfer ...... atment of chronic hepatitis C.

@en

type

label

Systematic review: peginterfer ...... atment of chronic hepatitis C.

@ast

Systematic review: peginterfer ...... atment of chronic hepatitis C.

@en

prefLabel

Systematic review: peginterfer ...... atment of chronic hepatitis C.

@ast

Systematic review: peginterfer ...... atment of chronic hepatitis C.

@en

P1433

Q35544070-457AAF11-0531-4B61-89FF-9D66D57817B7

P1476

Q35544070-200ED194-9C88-4C5F-9296-79A86025CB66

P2093

Q35544070-942B7818-FF04-4808-93A2-08958285F3B2

Q35544070-ADF637F7-D719-414E-8B45-9AFC0B32CECE

Q35544070-BBC1BA45-871B-416F-B4F4-AF731A69C894

P2860

Q35544070-14C57E20-418D-4989-BF9A-4A31A4260656

Q35544070-4768F2B0-33F7-494D-B99A-690928E8A1CA

Q35544070-7CE686D4-F7CE-4CBE-9238-F4C374989600

Q35544070-85A42CB4-C99B-4747-A075-CD1AD09A262E

Q35544070-8DB0CBF3-A79A-43DC-96B5-296D3632F704

Q35544070-B7FF7E9B-B3D8-44FC-9E73-A509C30D582F

Q35544070-D2D2C3B1-BAB6-40D5-938F-1F78C3D00781

Q35544070-D34E39DD-A41C-4B24-8104-E7D8750E80E1

Q35544070-E57F0D51-14E0-4E9E-B6EE-A25729D6C2C3

Q35544070-FD88F073-4C8A-4649-9E90-35FDA0D7BD7E

P304

Q35544070-FFCEBEC2-7468-4EBC-A6DC-45654F9067A3

P31

Q35544070-F899158E-ACDB-4CA6-8A28-8ABC95633009

P356

Q35544070-75474667-4B18-4D69-88E5-023A55789465

P407

Q35544070-EECC2DFD-0848-4611-9EFB-0030135A2037

P433

Q35544070-B4F5BF35-1F6D-4D73-92D9-9AD074F15575

P478

Q35544070-E181F550-0F32-44A3-A346-364889367B4D

P577

Q35544070-34BAA69B-3820-4A34-9803-F5A3A16AF570

P5875

Q35544070-5D885FFB-B855-4DAC-9550-476F22195ADD

P698

Q35544070-E9F3E897-92EC-4DD4-8331-8B5236052E4C

P356

J.1365-2036.2003.01747.X

P1433

Alimentary Pharmacology & Therapeutics

P1476

Systematic review: peginterfer ...... atment of chronic hepatitis C.

@en

P2093

A Zaman

http://www.w3.org/2001/XMLSchema#string

E B Keeffe

http://www.w3.org/2001/XMLSchema#string

M B Fennerty

http://www.w3.org/2001/XMLSchema#string

P2860

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group.

Peginterferon alfa-2a in patients with chronic hepatitis C.

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis.

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration

P304

661-670

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2036.2003.01747.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229730416

http://www.w3.org/2001/XMLSchema#string

P698

14510739

http://www.w3.org/2001/XMLSchema#string